Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Sexually Transmitted Infections (STIs) Global Market Report 2025
Download Free Sample Buy Now
Global Sexually Transmitted Infections (STIs) Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Sexually Transmitted Infections (STIs) Global Market Report 2025

By Type (Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types), By Treatment (Antibiotics, Antiviral), By Location Of Testing (Laboratory Testing, Point-Of-Care (POC) Testing), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Sexually Transmitted Infections (STIs) Market Overview

• Sexually Transmitted Infections (STIs) market size has reached to $63.69 billion in 2024

• Expected to grow to $112.02 billion in 2029 at a compound annual growth rate (CAGR) of 12%

• Growth Driver: Government Initiatives Fueling Growth In The Sexually Transmitted Infections (STIS) Market

• Market Trend: Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Sexually Transmitted Infections (STIs) Market?

Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), refer to diseases caused by viruses, bacteria and parasites that are passed from one person to another through sexual contact. These infections can be transmitted by vaginal, anal and oral sex and through skin-to-skin contact.

The main types of sexually transmitted infections (STIs) are Human Immunodeficiency Virus (HIV), human papillomavirus (HPV); gonorrhea, syphilis and others. Human Immunodeficiency Virus (HIV) is a virus that affects the body's immune system by killing a type of white blood cell that aids in infection resistance. The various treatments are antibiotics and antivirals in various locations of testing such as laboratory testing and point-of-care (POC) testing. The various routes of administration are oral, parenteral and others used in hospitals, specialty clinics, homecare and others.

Sexually Transmitted Infections (STIs) Market Size and growth rate 2025 to 2029: Graph

What Is The Sexually Transmitted Infections (STIs) Market Size 2025 And Growth Rate?

The sexually transmitted infections (STIs) market size has grown rapidly in recent years. It will grow from $63.69 billion in 2024 to $71.28 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to behavioral factors, education and awareness, healthcare access, antibiotic development.

What Is The Sexually Transmitted Infections (STIs) Market Growth Forecast?

The sexually transmitted infections (STIs) market size is expected to see rapid growth in the next few years. It will grow to $112.02 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to emerging sti strains, vaccination initiatives, telemedicine and at-home testing, sexual health equity. Major trends in the forecast period include rise of antimicrobial resistance, pre-exposure prophylaxis (prep), sti self-management, enhanced sexual education.

The forecast of 12.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of multiplex Polymerase Chain Reaction Sexually Transmitted Infection panels and rapid syphilis tests sourced from Belgium and China, thereby delaying diagnosis and elevating public health screening program costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Sexually Transmitted Infections (STIs) Market Segmented?

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types

2) By Treatment: Antibiotics, Antiviral

3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2

2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV

3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea

4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis

5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, hepatitis c, Trichomoniasis

What Is Driving The Sexually Transmitted Infections (STIs) Market? Government Initiatives Fueling Growth In The Sexually Transmitted Infections (STIS) Market

The surge in government initiatives for spreading awareness of sexually transmitted infections is expected to propel the growth of the sexually transmitted infections (STIs) market going forward. A government initiative is a program or policy implemented to achieve a specific goal and address particular problems. The government offers several initiatives to prevent, control and treat sexually transmitted infections (STIs), such as funds for public education campaigns to raise awareness of STIs, vaccines to prevent certain STIs and free or low-cost screening and testing. For instance, in April 2023, Springfield-Greene County Health, a US-based public health department, announced Disease Intervention Specialist (DIS), a new program and partnership with the Missouri Department of Health and Senior Services (Missouri DHSS) to combat the rising spread of sexually transmitted infections (STIs) in Greene County. The two experts in the DIS program, who will primarily focus on syphilis and HIV, will contact those who test positive for these illnesses, connect them with options for treatment and help identify and get in touch with them to make them aware of the infection. Therefore, the surge in government initiatives will drive the sexually transmitted infections (STIs) industry.

What Is Driving The Sexually Transmitted Infections (STIs) Market? Rising Prevalence Of Unprotected Sex Spurs Growth In The Sexually Transmitted Infections (STIS) Market

The increasing culture of unprotected sex is expected to boost the growth of sexually transmitted infections (STIs) market going forward. The rising culture of unprotected sex indicates a practice in which people indulge in sexual activities without utilizing protection, such as condoms, which can contribute to the spread of sexually transmitted illnesses (STIs). For instance, in August 2024, according to the World Health Organization, a UK-based intergovernmental organization, in 2022, the percentage of sexually active adolescents using condoms at their most recent intercourse decreased, with 61% of boys and 57% of girls reporting condom use, down from 70% and 63%, respectively. Therefore, the increasing culture of unprotected sex is driving the sexually transmitted infections (STIs) industry.

Who Are The Major Players In The Global Sexually Transmitted Infections (STIs) Market?

Major companies operating in the sexually transmitted infections (STIs) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

What Are The Key Trends Of The Global Sexually Transmitted Infections (STIs) Market? Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market

Major companies operating in the sexually transmitted infections (STIs) market are developing innovative products with fluorescent PCR technology to gain a competitive advantage in the market. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique that detects and quantifies specific DNA sequences in a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymer chain reaction (PCR) kits, Mycoplasma Hominis Real-Time PCR Kit and Treponema Pallidum Real-Time PCR Kit. These Kits provide a complete PCR solution for early diagnosis of sexually transmitted illnesses, which impact many individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that uses fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market? Caraway Health And Ash Wellness Inc. Join Forces To Tackle Rising Sti Rates Among Gen Z In Universities

In February 2023, Caraway Health, a US-based provider of digital healthcare company for Gen Z, partnered with Ash Wellness Inc. for an undisclosed amount. The partnership addresses the surge in sexually transmitted infections (STI) in universities. The collaboration gives Generation Z the tools they require to prioritize sexual well-being on personal terms. Ash Wellness Inc. is a US-based provider of remote diagnostic solutions such as home HIV and STI testing.

Regional Outlook For The Global Sexually Transmitted Infections (STIs) Market

North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Sexually Transmitted Infections (STIs) Market?

The sexually transmitted infections (STIs) market consists of revenues earned by entities by providing services such as treatment, testing, awareness programs and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infections (STIs) market also includes the sales of treatments such as testing kits, vaccines and medication. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Sexually Transmitted Infections (STIs) Industry?

The sexually transmitted infections (stis) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sexually transmitted infections (stis) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Sexually Transmitted Infections (STIs) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $71.28 billion
Revenue Forecast In 2034 $112.02 billion
Growth Rate CAGR of 12% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users Subsegments: 1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Sexually Transmitted Infections (STIs) Market Characteristics

3. Sexually Transmitted Infections (STIs) Market Trends And Strategies

4. Sexually Transmitted Infections (STIs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sexually Transmitted Infections (STIs) Growth Analysis And Strategic Analysis Framework

5.1. Global Sexually Transmitted Infections (STIs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Sexually Transmitted Infections (STIs) Market Growth Rate Analysis

5.4. Global Sexually Transmitted Infections (STIs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Sexually Transmitted Infections (STIs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Sexually Transmitted Infections (STIs) Total Addressable Market (TAM)

6. Sexually Transmitted Infections (STIs) Market Segmentation

6.1. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Immunodeficiency Virus (HIV)

Human Papilloma Virus (HPV)

Gonorrhea

Syphilis

Other Types

6.2. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antibiotics

Antiviral

6.3. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laboratory Testing

Point-Of-Care (POC) Testing

6.4. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route Of Administration

6.5. Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Homecare

Other End-Users

6.6. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

HIV Type 1

HIV Type 2

6.7. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Low-Risk HPV

High-Risk HPV

6.8. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Uncomplicated Gonorrhea

Complicated Gonorrhea

6.9. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Primary Syphilis

Secondary Syphilis

Tertiary Syphilis

6.10. Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chlamydia

Herpes Simplex Virus (HSV)

Hepatitis B

Hepatitis C

Trichomoniasis

7. Sexually Transmitted Infections (STIs) Market Regional And Country Analysis

7.1. Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sexually Transmitted Infections (STIs) Market

8.1. Asia-Pacific Sexually Transmitted Infections (STIs) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sexually Transmitted Infections (STIs) Market

9.1. China Sexually Transmitted Infections (STIs) Market Overview

9.2. China Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sexually Transmitted Infections (STIs) Market

10.1. India Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sexually Transmitted Infections (STIs) Market

11.1. Japan Sexually Transmitted Infections (STIs) Market Overview

11.2. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sexually Transmitted Infections (STIs) Market

12.1. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sexually Transmitted Infections (STIs) Market

13.1. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sexually Transmitted Infections (STIs) Market

14.1. South Korea Sexually Transmitted Infections (STIs) Market Overview

14.2. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sexually Transmitted Infections (STIs) Market

15.1. Western Europe Sexually Transmitted Infections (STIs) Market Overview

15.2. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sexually Transmitted Infections (STIs) Market

16.1. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sexually Transmitted Infections (STIs) Market

17.1. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sexually Transmitted Infections (STIs) Market

18.1. France Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sexually Transmitted Infections (STIs) Market

19.1. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sexually Transmitted Infections (STIs) Market

20.1. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sexually Transmitted Infections (STIs) Market

21.1. Eastern Europe Sexually Transmitted Infections (STIs) Market Overview

21.2. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sexually Transmitted Infections (STIs) Market

22.1. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sexually Transmitted Infections (STIs) Market

23.1. North America Sexually Transmitted Infections (STIs) Market Overview

23.2. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sexually Transmitted Infections (STIs) Market

24.1. USA Sexually Transmitted Infections (STIs) Market Overview

24.2. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sexually Transmitted Infections (STIs) Market

25.1. Canada Sexually Transmitted Infections (STIs) Market Overview

25.2. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sexually Transmitted Infections (STIs) Market

26.1. South America Sexually Transmitted Infections (STIs) Market Overview

26.2. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sexually Transmitted Infections (STIs) Market

27.1. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sexually Transmitted Infections (STIs) Market

28.1. Middle East Sexually Transmitted Infections (STIs) Market Overview

28.2. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sexually Transmitted Infections (STIs) Market

29.1. Africa Sexually Transmitted Infections (STIs) Market Overview

29.2. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sexually Transmitted Infections (STIs) Market Competitive Landscape And Company Profiles

30.1. Sexually Transmitted Infections (STIs) Market Competitive Landscape

30.2. Sexually Transmitted Infections (STIs) Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Roche Holdings AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sexually Transmitted Infections (STIs) Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Sanofi SA

31.3. Bristol-Myers Squibb

31.4. Astra Zeneca Pharmaceuticals LP

31.5. GlaxoSmithKline plc

31.6. Takeda Pharmaceutical Company Limited

31.7. Gilead Sciences Inc.

31.8. Viatris Inc.

31.9. Teva Pharmaceutical Industries Ltd.

31.10. Astellas Pharma Inc.

31.11. Daiichi Sankyo Co. Ltd.

31.12. Hetero Drugs Ltd.

31.13. Eisai Co. Ltd.

31.14. Boehringer Ingelheim Group

31.15. Sun Pharmaceutical Industries Ltd.

32. Global Sexually Transmitted Infections (STIs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market

34. Recent Developments In The Sexually Transmitted Infections (STIs) Market

35. Sexually Transmitted Infections (STIs) Market High Potential Countries, Segments and Strategies

35.1 Sexually Transmitted Infections (STIs) Market In 2029 - Countries Offering Most New Opportunities

35.2 Sexually Transmitted Infections (STIs) Market In 2029 - Segments Offering Most New Opportunities

35.3 Sexually Transmitted Infections (STIs) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: Johnson & Johnson Financial Performance
  • Table 83: Roche Holdings AG Financial Performance
  • Table 84: Merck & Co Inc. Financial Performance
  • Table 85: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Immunodeficiency Virus (HIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Human Papilloma Virus (HPV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Gonorrhea, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Syphilis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Sexually Transmitted Infections (STIs) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: Johnson & Johnson Financial Performance
  • Figure 83: Roche Holdings AG Financial Performance
  • Figure 84: Merck & Co Inc. Financial Performance
  • Figure 85: AbbVie Inc. Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Read More About From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Read More About Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Sexually Transmitted Infections (STIs) Global Market Report 2025 – By Type (Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types), By Treatment (Antibiotics, Antiviral), By Lo...

View Report

STD Diagnostics Global Market Report 2025 – By Type( Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Te...

View Report

Chlamydia Infection Diagnostics Global Market Report 2025 – By Test Type (Culture Test, Nucleic Acid Amplification Test (NAAT), Direct Fluorescent Antibody Test, Serology Test, Other Test Types), By Type Of Infections (G...

View Report

Genital Herpes Global Market Report 2025 – By Type (Diagnosis, Treatment), By Route Of Administration ( Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channel)...

View Report

Chlamydia Trachomatis (CT) And Neisseria Gonorrhoeae (NG) Testing Global Market Report 2025 – By Test Type (Laboratory, Point Of Care Testing), By Product (Assays And Kits, Instruments Or Analyzers), By Technology (Isoth...

View Report

Chlamydia Infection Diagnostics And Therapeutics Global Market Report 2025 – By Type (Nucleic Acid Amplification Tests (NAATS), Direct Fluorescent Tests, Macrolides, Quinolones, Sulfonamides, Tetracycline, Aminopenicilli...

View Report

Chlamydia Infection Treatment Global Market Report 2025 – By Treatment (Chlamydia Culture, Urine Culture, Enzyme Immunoassays, Nucleic Acid Amplification Test), By Causative Organisms (Chlamydia Trachomatis, Chlamydophil...

View Report

Infection Prevention Global Market Report 2025 – By Product (Sterilization Equipment, Disinfectors, Consumables), By Infection Type (Microbial Infections, Healthcare Associated Infections), By End User (Hospitals And Cli...

View Report

Frequently Asked Questions

Sexually transmitted infections (STIs), also known as sexually transmitted diseases (STDs), refer to diseases caused by viruses, bacteria and parasites that are passed from one person to another through sexual contact. These infections can be transmitted by vaginal, anal and oral sex and through skin-to-skin contact. For further insights on this market, request a sample here

The market major growth driver - Government Initiatives Fueling Growth In The Sexually Transmitted Infections (STIS) Market. For further insights on this market, request a sample here

The sexually transmitted infections (stis) market size has grown rapidly in recent years. It will grow from $63.69 billion in 2024 to $71.28 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to behavioral factors, education and awareness, healthcare access, antibiotic development. The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to " $112.02 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be attributed to emerging sti strains, vaccination initiatives, telemedicine and at-home testing, sexual health equity. Major trends in the forecast period include rise of antimicrobial resistance, pre-exposure prophylaxis (prep), sti self-management, enhanced sexual education. For further insights on this market, request a sample here

The sexually transmitted infections (stis)market covered in this report is segmented –
1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
2) By Treatment: Antibiotics; Antiviral
3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1; HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV; High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea; Complicated Gonorrhea
4) By Syphilis: Primary Syphilis; Secondary Syphilis; Tertiary Syphilis
5) By Other Types: Chlamydia; Herpes Simplex Virus (HSV); Hepatitis B; Hepatitis C; Trichomoniasis For further insights on this market, request a sample here

North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.. For further insights on this market, request a sample here.

Major trends in this market include Innovative Fluorescent Pcr Technology Advancements By Leading Companies In The Sexually Transmitted Infections (STIS) Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Sexually Transmitted Infections (STIs) Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon